1,962,523 The Chemours Company $CC Shares Purchased by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. lifted its position in The Chemours Company (NYSE:CC) by 251.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,742,068 shares of the specialty chemicals company’s stock after acquiring an additional 1,962,523 shares during the quarter. Jefferies Financial Group Inc. owned approximately 1.82% of Chemours worth $37,210,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. BlackRock Inc. bought a new position in shares of Chemours during the second quarter valued at about $477,769,000. Wolf Hill Capital Management LP bought a new stake in Chemours in the 2nd quarter worth about $59,698,056. Bank of New York Mellon Corp bought a new stake in Chemours in the 2nd quarter worth about $33,353,000. Legal & General Group Plc purchased a new stake in Chemours in the 2nd quarter valued at about $28,400,000. Finally, Bank of America Corp DE increased its stake in Chemours by 79.1% in the 1st quarter. Bank of America Corp DE now owns 1,317,003 shares of the specialty chemicals company’s stock valued at $29,014,000 after buying an additional 581,621 shares during the last quarter. Hedge funds and other institutional investors own 76.26% of the company’s stock.

Chemours News Roundup

These are some of the CC news items that stood out recently:

• Neutral Sentiment: Investors bought 21,465 Chemours call options on Wednesday, about 633% above the average volume of 2,930. This indicates unusually active options trading, but does not establish a clear direction for the stock. No article link was provided.
• Negative Sentiment: Multiple law firms reminded investors that December 7, 2026 is the deadline to seek lead-plaintiff status in a securities class action covering purchases from February 20 to August 4, 2026. The complaint alleges Chemours misrepresented demand for its Opteon refrigerants, including that strong 2025 sales masked an overfilled distribution channel and weaker underlying demand. These are allegations, not proven findings; the litigation could add uncertainty and potential costs. Article: CC Shareholder Alert
• Negative Sentiment: JPMorgan issued a pessimistic forecast for Chemours shares, adding to bearish sentiment. The supplied article information does not specify its price target or rationale. Article: JPMorgan Chase Issues Pessimistic Forecast for Chemours

Chemours Price Performance

Shares of NYSE:CC opened at $13.73 on Thursday. The company has a market capitalization of $2.07 billion, a P/E ratio of -13.47 and a beta of 1.47. The company’s 50-day moving average is $13.84 and its 200 day moving average is $18.18. The company has a debt-to-equity ratio of 24.25, a quick ratio of 0.98 and a current ratio of 1.81. The Chemours Company has a fifty-two week low of $10.44 and a fifty-two week high of $28.67.

Chemours (NYSE:CC) last posted its quarterly earnings data on Monday, November 2nd. The specialty chemicals company reported $0.21 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.05). The company had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.53 billion. Chemours had a positive return on equity of 76.52% and a negative net margin of 2.64%. The business’s quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter last year, the business posted $0.40 EPS. On average, equities research analysts forecast that The Chemours Company will post 0.82 earnings per share for the current year.

Chemours Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, November 16th will be given a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Monday, November 16th. Chemours’s dividend payout ratio is currently -34.31%.

Analyst Ratings Changes

CC has been the topic of several recent analyst reports. Barclays initiated coverage on shares of Chemours in a research report on Monday, October 12th. They set an “equal weight” rating and a $16.00 target price on the stock. BMO Capital Markets reduced their target price on Chemours from $26.00 to $18.00 and set an “outperform” rating for the company in a report on Thursday, August 13th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Chemours in a report on Tuesday, November 3rd. UBS Group decreased their price target on Chemours from $16.00 to $15.00 and set a “neutral” rating for the company in a research report on Wednesday, November 4th. Finally, Morgan Stanley set a $18.00 price target on Chemours in a research report on Monday, August 10th. Three equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Chemours has a consensus rating of “Hold” and an average price target of $17.36.

About Chemours

The Chemours Company is a global chemicals manufacturer spun off from DuPont in 2015 and headquartered in Wilmington, Delaware. It develops and produces materials used in industries ranging from construction and transportation to electronics and energy. Chemours’ Titanium Technologies business makes titanium dioxide (TiO?) pigment, sold under the Ti-Pure brand, which is used to add whiteness, brightness and opacity to products such as paints, coatings, plastics and paper. Its Thermal & Specialized Solutions business supplies refrigerants, foam-blowing agents and other specialty fluids, including products marketed under the Opteon and Freon brands.